Market revenue in 2024 | USD 8,268.0 million |
Market revenue in 2030 | USD 8,680.7 million |
Growth rate | 1.4% (CAGR from 2025 to 2030) |
Largest segment | Antivirals |
Fastest growing segment | Antifungals |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antibacterials, Antivirals, Antifungals |
Key market players worldwide | Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-infective agents market will help companies and investors design strategic landscapes.
Antivirals was the largest segment with a revenue share of 62.09% in 2024. Horizon Databook has segmented the UK anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2018 to 2030.
The anti-infective agents market in the UK is experiencing significant growth, largely driven by the government's proactive action plan on antimicrobial resistance (AMR). In May 2024, UK health officials announced a new five-year national action plan on antimicrobial resistance (AMR) covering the period from 2024 to 2029.
The earlier plan also led to the development of enhanced surveillance systems and the pilot implementation of a subscription-style antibiotic payment scheme within the National Health Service. This plan includes initiatives to enhance public awareness, improve surveillance of resistance patterns, and encourage better prescribing practices among healthcare professionals.
Horizon Databook provides a detailed overview of country-level data and insights on the UK anti-infective agents market , including forecasts for subscribers. This country databook contains high-level insights into UK anti-infective agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account